Compounds for the treatment of metabolic disorders

Details Compounds for the treatment of metabolic disorders Compounds for the treatment of metabolic disorders

2007-02-09

2011-10-25

Sullivan, Daniel (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Amino nitrogen containing

C570S126000, C570S127000, C570S101000

Reexamination Certificate

active

08044243

ABSTRACT:
Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, polycystic ovary syndrome, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed. Formula (I) wherein n is 1 or 2; q is 0 or 1; t is 0 or 1; R1is alkyl having from 1 to 3 carbon atoms; R2is hydrogen, halo, alkyl having from 1 to 3 carbon atoms, or alkoxy having from 1 to 3 carbon atoms; A is unsubstituted or substituted phenyl; or cycloalkyl; or a 5 or 6 membered heteroaromatic ring. Alternatively, the agent can be a pharmaceutically acceptable salt of the compound of Formula I.

REFERENCES:
patent: 6232322 (2001-05-01), Malamas et al.
patent: 6307080 (2001-10-01), Pischel et al.
patent: 6858602 (2005-02-01), Sharma et al.
patent: 6916848 (2005-07-01), Sharma
patent: 6924314 (2005-08-01), Sharma et al.
patent: 6946491 (2005-09-01), Sharma et al.
patent: 7012071 (2006-03-01), Sharma et al.
patent: 7041659 (2006-05-01), Sharma
patent: 7045541 (2006-05-01), Sharma
patent: 7101910 (2006-09-01), Sharma
patent: 7329782 (2008-02-01), Sharma et al.
patent: 7361686 (2008-04-01), Hodge et al.
patent: 7442796 (2008-10-01), Sharma et al.
patent: 2002/0064847 (2002-05-01), Yamamoto et al.
patent: 2005/0090555 (2005-04-01), Sharma et al.
patent: 2006/0014784 (2006-01-01), Hodge et al.
patent: 2006/0035970 (2006-02-01), Hodge et al.
patent: 2006/0247309 (2006-11-01), Hodge et al.
patent: 2007/0105958 (2007-05-01), Sharma et al.
patent: 2007/0249696 (2007-10-01), Sharma et al.
patent: 2007/0249719 (2007-10-01), Sharma et al.
patent: 2007/0265322 (2007-11-01), Sharma et al.
patent: 2007/0282003 (2007-12-01), Sharma et al.
patent: 2008/0015209 (2008-01-01), Sharma et al.
patent: 2008/0015254 (2008-01-01), Hodge et al.
patent: 2008/0021109 (2008-01-01), Sharma et al.
patent: 2008/0027229 (2008-01-01), Hodge et al.
patent: 2249309 (1992-05-01), None
patent: 07089898 (1995-04-01), None
patent: 02/100341 (2002-12-01), None
patent: 2004/073611 (2004-09-01), None
patent: 2004/091486 (2004-10-01), None
Younis, et al., “The prevention of type 2 diabetes mellitus: recent advances”, QJ Med., vol. 97, pp. 451-455, 2004.
Goff, et al., “Prevention of Cardiovascular Disease in Persons with type 2 diabetes Mellitus: Current Knowledge and Rational for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial”, AM J Cardiol., 99(12A): S4-S20, 2007. (Abstract).
Knowler, et al., “Perspectives in Diabetes: Preventing Non-Insulin-Dependent Diabetes”, Diabetes, vol. 44, pp. 483-488, 1995.
Pending (as of Mar. 24, 2008) claims from U.S. Appl. No. 11/772,515.
Pending (as of Mar. 24, 2008) claims from U.S. Appl. No. 11/772,520.
Pending (as of Mar. 24, 2008) claims from U.S. Appl. No. 11/772,560.
Pending (as of Sep. 25, 2008) claims from U.S. Appl. No. 12/294,530.
Pending (as of Jul. 14, 2008) claims from U.S. Appl. No. 12/160,857.
Pending (as of Jul. 28, 2008) claims from U.S. Appl. No. 12/162,397.
Pending (as of May 7, 2008) claims from U.S. Appl. No. 12/092,932.
Pending (as of Aug. 18, 2008) claims from U.S. Appl. No. 12/160,808.
Pending (as of Jul. 14, 2008) claims from U.S. Appl. No. 12/160,858.
Pending (as of Jul. 14, 2008) claims from U.S. Appl. No. 12/160,854.

Affiliated with

Also associated with

Rating

Compounds for the treatment of metabolic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds for the treatment of metabolic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for the treatment of metabolic disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4290799